Company: SACH
Filing Date: 2025-11-14
Form Type: 424B2
Source: 0001628280-25-052333
Chunk: 25

Company: Sachem Capital Corp.
Filing Date: 2025-11-14
Form: 424B2
Chunk 25
---
 Series A Preferred Stock may be limited and the market value of the Series A Preferred Stock will likely be materially adversely affected.

It is not possible to predict the actual number of Series A Preferred Stock we will sell under the Sales Agreement, or the gross proceeds resulting from those sales.

Subject to certain limitations in the Sales Agreement and compliance with applicable law, we have the discretion to deliver a placement notice to either of the Selling Agents at any time throughout the term of the Sales Agreement. The number of Series A Preferred Stock that are sold through a Selling Agent after delivering a placement notice will fluctuate based on a number of factors, including the market price of the Series A Preferred Stock during the sales period, the limits we set with a Selling Agent in any applicable placement notice, and the demand for our Series A Preferred Stock during the sales period. Because the price per share of each share sold will fluctuate during the sales period, it is not currently possible to predict the number of shares that will be sold or the gross proceeds to be raised in connection with those sales.

The Series A Preferred Stock offered hereby will be sold in an “at the market offering,” and investors who buy shares at different times will likely pay different prices.

Investors who purchase Series A Preferred Stock in this offering at different times will likely pay different prices, and so may experience different levels of dilution and different outcomes in their investment results. We will have discretion, subject to market demand, to vary the timing, prices, and numbers of shares sold in this offering. In addition, there is no minimum or maximum sales price for shares to be sold in this offering. Investors may experience a decline in the value of the shares they purchase in this offering as a result of sales made at prices lower than the prices they paid.

Management has broad discretion to invest or spend the net proceeds from this offering and you may not agree with their strategy.

Management will have broad discretion over the use of thee proceeds from this offering. As currently contemplated, management intends to use the net proceeds from this offering primarily for working capital and general corporate purposes but even within those broad categories management will have considerable discretion over the application of the net proceeds and shareholders will not have any opportunity to assess whether the proceeds are being used appropriately or in manner that they approve. If management fails to use these funds effectively our business, operations and financial condition could be adversely impacted and the price of publicly traded securities, including the Series A Preferred Stock, could decline. It could also adversely impact our ability to pay dividends. Pending their use, the